Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
Y Otaki, T Watanabe, D Kinoshita, M Yokoyama… - International journal of …, 2017 - Elsevier
Background Oxidative stress due to purine degradation is associated with the development
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …
Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
Y Otaki, T Watanabe, D Kinoshita, M Yokoyama… - International Journal of …, 2017 - infona.pl
Oxidative stress due to purine degradation is associated with the development of chronic
heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of purine …
heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of purine …
Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
Y Otaki, T Watanabe… - International …, 2017 - internationaljournalofcardiology.com
Background Oxidative stress due to purine degradation is associated with the development
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …
Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
Y Otaki, T Watanabe, D Kinoshita… - International …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Oxidative stress due to purine degradation is associated with the development
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …
[引用][C] Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure
Y Otaki, T Watanabe, D Kinoshita… - International Journal of …, 2017 - cir.nii.ac.jp
Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in
patients with chronic heart failure | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
patients with chronic heart failure | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
Y Otaki, T Watanabe, D Kinoshita… - … Journal of Cardiology, 2016 - europepmc.org
Background Oxidative stress due to purine degradation is associated with the development
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …
of chronic heart failure (CHF). Xanthine oxidoreductase (XOR) is a rate-limiting enzyme of …